1750 related articles for article (PubMed ID: 34118952)
1. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and Cancer: Discovery of Difference in Clinical Immune Indexes.
Zeng X; Jiang X; Yang L; Pan Y; Li Y
J Immunol Res; 2021; 2021():8669098. PubMed ID: 34712741
[TBL] [Abstract][Full Text] [Related]
3. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19.
Liu Y; Liao W; Wan L; Xiang T; Zhang W
Viral Immunol; 2021 Jun; 34(5):330-335. PubMed ID: 32297828
[TBL] [Abstract][Full Text] [Related]
4. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
[TBL] [Abstract][Full Text] [Related]
5. Long-term infection of SARS-CoV-2 changed the body's immune status.
Lin L; Luo S; Qin R; Yang M; Wang X; Yang Q; Zhang Y; Wang Q; Zhu R; Fan H; Wang H; Hu Y; Wang L; Hu D
Clin Immunol; 2020 Sep; 218():108524. PubMed ID: 32659373
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
[TBL] [Abstract][Full Text] [Related]
7. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.
Schub D; Klemis V; Schneitler S; Mihm J; Lepper PM; Wilkens H; Bals R; Eichler H; Gärtner BC; Becker SL; Sester U; Sester M; Schmidt T
JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32937615
[TBL] [Abstract][Full Text] [Related]
8. Continuous tracking of COVID-19 patients' immune status.
Guan J; Wei X; Qin S; Liu X; Jiang Y; Chen Y; Chen Y; Lu H; Qian J; Wang Z; Lin X
Int Immunopharmacol; 2020 Dec; 89(Pt A):107034. PubMed ID: 33039966
[TBL] [Abstract][Full Text] [Related]
9. Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19.
Hasichaolu ; Zhang X; Li X; Li X; Li D
Biomed Res Int; 2020; 2020():7570981. PubMed ID: 33274223
[TBL] [Abstract][Full Text] [Related]
10. Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection.
Luo Y; Mao L; Yuan X; Xue Y; Lin Q; Tang G; Song H; Wang F; Sun Z
J Clin Immunol; 2020 Oct; 40(7):960-969. PubMed ID: 32661797
[TBL] [Abstract][Full Text] [Related]
11. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
Front Immunol; 2020; 11():596684. PubMed ID: 33362779
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the SARS-CoV-2 positivity ratio and upper respiratory tract viral load among asymptomatic individuals screened before hospitalization or surgery in Flanders, Belgium.
Heireman L; Abrams S; Bruynseels P; Cartuyvels R; Cuypers L; De Schouwer P; Laffut W; Lagrou K; Hens N; Ho E; Padalko E; Reynders M; Vandamme S; Van der Moeren N; Verstrepen W; Willems P; Naesens R
PLoS One; 2021; 16(11):e0259908. PubMed ID: 34762704
[TBL] [Abstract][Full Text] [Related]
13. CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.
Calvet J; Gratacós J; Amengual MJ; Llop M; Navarro M; Moreno A; Berenguer-Llergo A; Serrano A; Orellana C; Cervantes M
Viruses; 2020 Nov; 12(11):. PubMed ID: 33182268
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study.
Zhang J; Wang Z; Wang X; Hu Z; Yang C; Lei P
Front Immunol; 2021; 12():581469. PubMed ID: 33664741
[No Abstract] [Full Text] [Related]
15. Descriptive, Retrospective Study of the Clinical Characteristics of Asymptomatic COVID-19 Patients.
Han H; Xu Z; Cheng X; Zhong Y; Yuan L; Wang F; Li Y; Liu F; Jiang Y; Zhu C; Xia Y
mSphere; 2020 Oct; 5(5):. PubMed ID: 33028689
[TBL] [Abstract][Full Text] [Related]
16. Viral Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients with Coronavirus Disease 2019.
Kim DY; Bae EK; Seo JW; Yun NR; Kim CM; Kim DM
Microbiol Spectr; 2021 Oct; 9(2):e0079321. PubMed ID: 34704783
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of cytokines and lymphocyte subsets associated with the poor prognosis of severe COVID-19.
Li Q; Xu W; Li WX; Huang CL; Chen L
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12536-12544. PubMed ID: 33336774
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of asymptomatic carriers of novel coronavirus disease 2019: A multi-center study in Jiangsu Province.
Chen J; Han T; Huang M; Yang Y; Shang F; Zheng Y; Zhao W; Luo L; Han X; Lin A; Zhao H; Gu Q; Shi Y; Li J; Xu X; Liu K; Deng Y; Jia E; Cao Q
Virulence; 2020 Dec; 11(1):1557-1568. PubMed ID: 33138692
[TBL] [Abstract][Full Text] [Related]
19. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients.
Wan S; Yi Q; Fan S; Lv J; Zhang X; Guo L; Lang C; Xiao Q; Xiao K; Yi Z; Qiang M; Xiang J; Zhang B; Chen Y; Gao C
Br J Haematol; 2020 May; 189(3):428-437. PubMed ID: 32297671
[TBL] [Abstract][Full Text] [Related]
20. Children and Adolescents With SARS-CoV-2 Infection: Epidemiology, Clinical Course and Viral Loads.
Maltezou HC; Magaziotou I; Dedoukou X; Eleftheriou E; Raftopoulos V; Michos A; Lourida A; Panopoulou M; Stamoulis K; Papaevangelou V; Petinaki E; Mentis A; Papa A; Tsakris A; Roilides E; Syrogiannopoulos GA; Tsolia M;
Pediatr Infect Dis J; 2020 Dec; 39(12):e388-e392. PubMed ID: 33031141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
